Lithium therapy and signal transduction. (Q52171133)

26 April 2018

title

Lithium therapy and signal transduction. (English)

1 reference

26 April 2018

author

Adrian J Harwood

series ordinal

2

1 reference

26 April 2018

author name string

Williams RS

series ordinal

1

1 reference

26 April 2018

publication date

1 February 2000

1 reference

26 April 2018

Trends in Pharmacological Sciences

published in

1 reference

26 April 2018

volume

21

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

61-64

1 reference

26 April 2018

Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Glycogen synthase kinase 3 regulates cell fate in Dictyostelium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

A molecular mechanism for the effect of lithium on development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormality.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Lithium stimulates gene expression through the AP-1 transcription factor pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Neural and developmental actions of lithium: a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Augmentation of lithium's behavioral effect by inositol uptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Proline specific peptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

"Subclinical" dosages of lithium and pilocarpine that do not evoke overt seizures affect long-term spatial memory but not learning in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901428-5

7 January 2021

10.1016/S0165-6147(99)01428-5

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

10664610

1 reference

26 April 2018